Christian Cardon
Chief Executive Officer at Ecuphar Invest NV
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeroen Bastijns | M | - |
Ecuphar NV
 Ecuphar NV Agricultural Commodities/MillingProcess Industries Ecuphar NV develops and markets veterinary products and services. It offers healthcare products and services for veterinarians and animal owners. The firm offers products for companion animals, large animals, and horses. The company was founded by Christian Cardon in 2003 and is headquartered in Oostkamp, Belgium.
Ecuphar Invest NV
 Ecuphar Invest NV Food DistributorsDistribution Services Ecuphar Invest NV is a Belgian company that manufactures pet related products. The company is based in Oostkamp, Belgium. The company was founded in 2001. Christian Cardon has been the CEO of the company since 2012. | 21 years |
| Olivier Lemaire | M | - |
Ziphius Vaccines NV
 Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | - |
| Edwin Torr | M | 63 | 7 years | |
| Jan Marcel Matthieu Boone | M | 53 | 7 years | |
| Jennifer Winter | F | 64 | 6 years | |
| Tom Almey | M | - |
Ziphius Vaccines NV
Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then.
Ghent University
| 5 years |
| Marc. A. A. A. L Coucke | M | 59 | 7 years | |
| Annie Vereecken | F | - |
Ziphius Vaccines NV
Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | - |
| Johan Van Hoof | M | - |
Ziphius Vaccines NV
Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | - |
| Griet Nuytinck | M | - |
Ziphius Vaccines NV
Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Iain D. Menneer | M | 54 | - | |
| Christian de Wolf | M | - |
Ghent University
| 9 years |
| James Scott Lambert | M | 66 | 11 years | |
| Luc van den Durpel | M | - |
Ghent University
| 4 years |
| Marion Debruyne | M | 52 |
Ghent University
| 11 years |
| Alain Bostoen | M | 54 |
Ghent University
Vlerick Leuven Gent Management School
| 4 years |
| Paul Demyttenaere | M | 62 |
Ghent University
| 5 years |
| Peter Meuris | M | - |
Ghent University
| 1 years |
| Bernard de Backer | M | - |
Ghent University
| 9 years |
| Thierry Saegeman | M | - |
Vlerick Leuven Gent Management School
Ghent University
| 5 years |
| Nathalie Sierens | F | - |
Vlerick Leuven Gent Management School
Ghent University
| 5 years |
| Walter Beyers | M | 64 | - | |
| Philippe Schaillee | M | 53 |
Vlerick Leuven Gent Management School
| 2 years |
| Berg de Bleecker | F | - |
Ghent University
| 5 years |
| Jan Willems | M | 49 |
Ghent University
| 4 years |
| Jo L. Goossens | M | 62 |
Vlerick Leuven Gent Management School
| 2 years |
| Peter Vanacker | M | 58 |
Ghent University
| 1 years |
| Rudi Vander Vennet | M | 59 |
Ghent University
| 3 years |
| Vincent Macharis | M | 52 |
Ghent University
| 2 years |
| Didier Casimiro | M | 57 |
Ghent University
| 4 years |
| Erik Mijten | M | - |
Ghent University
| 4 years |
| Lieven Huysse | M | - |
Ghent University
| 3 years |
| Davy Ringoot | M | - |
Ghent University
| 5 years |
| Alexey Yankevich | M | 50 |
Vlerick Leuven Gent Management School
| 4 years |
| Peter Parmentier | M | - |
Vlerick Leuven Gent Management School
| 1 years |
| Wim van Criekinge | M | 53 |
Ghent University
| 4 years |
| Luc Vauterin | M | - |
Ghent University
| 3 years |
| Kristel Verleyen | F | 53 |
Ghent University
| 3 years |
| Jacques Vandermeiren | M | 61 |
Vlerick Leuven Gent Management School
| 4 years |
| Dany Vandevelde | M | - |
Ghent University
| 5 years |
| Sam Sabbe | M | 59 |
Ecuphar NV
Ecuphar NV Agricultural Commodities/MillingProcess Industries Ecuphar NV develops and markets veterinary products and services. It offers healthcare products and services for veterinarians and animal owners. The firm offers products for companion animals, large animals, and horses. The company was founded by Christian Cardon in 2003 and is headquartered in Oostkamp, Belgium. | - |
| Wim van Camp | M | - |
Ghent University
| 3 years |
| Koen Hoffman | M | 56 |
Ghent University
| 1 years |
| Geert Heyse | M | - |
Ghent University
| 1 years |
| Jan Holvoet | M | 55 |
Ghent University
| 5 years |
| Isabelle Desmeytere | F | 48 |
Ghent University
| 4 years |
| Vera Goossens | M | - |
Ghent University
| 3 years |
| Mario Haneca | M | 52 |
Ghent University
| 4 years |
| Lode van Mullem | M | - |
Ecuphar NV
Ecuphar NV Agricultural Commodities/MillingProcess Industries Ecuphar NV develops and markets veterinary products and services. It offers healthcare products and services for veterinarians and animal owners. The firm offers products for companion animals, large animals, and horses. The company was founded by Christian Cardon in 2003 and is headquartered in Oostkamp, Belgium. | 11 years |
| Carla de Schepper | F | - |
Ecuphar NV
Ecuphar NV Agricultural Commodities/MillingProcess Industries Ecuphar NV develops and markets veterinary products and services. It offers healthcare products and services for veterinarians and animal owners. The firm offers products for companion animals, large animals, and horses. The company was founded by Christian Cardon in 2003 and is headquartered in Oostkamp, Belgium. | 8 years |
| Simon McDermott | M | - |
Vlerick Leuven Gent Management School
| 2 years |
| Davy Vandenheede | M | - |
Ghent University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Belgium | 45 | 86.54% |
| United Kingdom | 7 | 13.46% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Christian Cardon
- Personal Network